Kate Middleton Receives Cancer Diagnosis: Know About Preventive Chemotherapy She Is Going Through
The recent emotional post shared by Kate Middleton, the Princess of Wales, has brought to light her ongoing battle with cancer. This news emerged through a video message from Kate herself, confirming her absence from public appearances was due to cancer treatment.
The princess’s announcement came shortly after Buckingham Palace disclosed on February 5 that King Charles was diagnosed with a form of cancer. Kate, aged 42, shared that her doctors had discovered cancer and she is currently undergoing early stages of treatment.
It has been disclosed by Kensington Palace that the princess began chemotherapy in February. This follows a “major abdominal surgery” she had on January 16, which was initially not thought to be related to cancer as tests had not revealed the presence of the disease. However, further tests post-surgery confirmed the malignancy.
Kate expressed gratitude towards the public for their support since her January hospitalization at The London Clinic. She was discharged on January 29 after a 13-day stay and has since been recuperating at the Windsor family home.
What Type Of Cancer Kate Middleton Is Battling With?
There is no specific information regarding what kind of cancer Kate is battling with.
What Is Preventive Chemotherapy That Kate Middleton Is Going Through
The term Preventive chemotherapy (PC) refers to treatment aimed at preventing cancer from returning post-surgery. According to health experts, this approach is typically considered for cancers where the risk of recurrence is significant. Decisions on administering chemotherapy post-surgery are influenced by the cancer’s stage, type, and sometimes the patient’s age. The goal is to eradicate any remaining cancer cells that could lead to recurrence.
What Are The Common Side Effects Of Preventive Chemotherapy? How Is It Administered?
Common side effects patients might experience include tiredness, nausea, an increased risk of infection, and a loss of appetite. Administered through tablets or injections, preventative chemotherapy usually spans four to six months.
Also, younger patients often have a higher tolerance for chemotherapy and might receive stronger treatment plans. Interestingly, the effectiveness of chemotherapy generally does not hinge on the patient’s age, except in cases involving immune hot cancer, where immunotherapy might be preferred.
Many undergoing this treatment may not currently have detectable cancer, but the therapy serves to minimize the risk of future recurrence. However, the uncertainty about the effectiveness of this preventive measure remains, as it’s challenging to ascertain whether all cancer cells have been successfully eliminated.
Boldsky Desk Boldsky
source: boldsky.com
